Biolife Solutions (BLFS) Other Non-Current Assets (2010 - 2026)
Biolife Solutions' (BLFS) quarterly Other Non-Current Assets came in at $3.0 million in Q1 2026, up 706.61% year-on-year from $378000.0 in Q1 2025, and little changed on a QoQ basis from $3.0 million in Q4 2025.
Biolife Solutions (BLFS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of Other Non-Current Assets data on file, last reported at $3.0 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 706.61% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 706.61% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, down 33.46% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for BLFS reached as high as $42.6 million in Q4 2023 and fell as low as $31000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $3.7 million across 5 years, with a median of $319500.0 in 2022.
- Across the five-year window, Other Non-Current Assets plunged 90.46% in 2022 and jumped 137441.94% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $31000.0 in 2022, then soared by 137441.94% to $42.6 million in 2023, then sank by 89.25% to $4.6 million in 2024, then slumped by 33.46% to $3.0 million in 2025, then dropped by 0.03% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn | 3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 378,000.00 |
| Dec 31, 2024 | 4.58 Mn |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | 42.64 Mn |
| Sep 30, 2023 | 316,000.00 |
| Jun 30, 2023 | 316,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 323,000.00 |
| Mar 31, 2022 | 265,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 386,000.00 |
| Jun 30, 2021 | 452,000.00 |
| Mar 31, 2021 | 356,000.00 |